Cargando…
Characterization of Phase I Hepatic Metabolites of Anti-Premature Ejaculation Drug Dapoxetine by UHPLC-ESI-Q-TOF
Determination of the metabolism pathway of xenobiotics undergoing the hepatic pass is a crucial aspect in drug development since the presence of toxic biotransformation products may result in significant side effects during the therapy. In this study, the complete hepatic metabolism pathway of dapox...
Autores principales: | Skibiński, Robert, Trawiński, Jakub, Gawlik, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270242/ https://www.ncbi.nlm.nih.gov/pubmed/34206424 http://dx.doi.org/10.3390/molecules26133794 |
Ejemplares similares
-
Photodegradation Study of Sertindole by UHPLC-ESI-Q-TOF and Influence of Some Metal Oxide Excipients on the Degradation Process
por: Trawiński, Jakub, et al.
Publicado: (2019) -
Dapoxetine and premature ejaculation
Publicado: (2023) -
Dapoxetine and the treatment of premature ejaculation
por: Sangkum, Premsant, et al.
Publicado: (2013) -
Efficacy of Dapoxetine in the Treatment of Premature Ejaculation
por: McMahon, Chris G.
Publicado: (2011) -
Emerging treatments for premature ejaculation: focus on dapoxetine
por: Hellstrom, Wayne JG
Publicado: (2009)